Last $33.73 USD
Change Today +0.3799 / 1.14%
Volume 73.5K
BRLI On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 2:03 PM 01/28/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for bio-reference labs inc (BRLI)

This company's debt to total capital ratio, at 14.81%, is in-line with the Healthcare Providers and Services industry's norm. Additionally, an examination of near-term assets and liabilities shows that there are enough liquid assets to satisfy current obligations.. Cash Collection is a strong suit as the company is more effective than most in the industry. As of the end of 2014, its uncollected receivables totaled $263.3M USD, which, at the current sales rate provides a Days Receivables Outstanding of 102.97. Last, inventories seem to be well managed as the Inventory Processing Period is typical for the industry, at 16.44 days.
Currency in
Millions of US Dollars
As of:Oct 31
2011
Reclassified
Oct 31
2012
Reclassified
Oct 31
2013
Oct 31
2014
4 Year
Trend
Assets    
Cash and Equivalents22.025.118.017.5
TOTAL CASH AND SHORT TERM INVESTMENTS22.025.118.017.5
TOTAL RECEIVABLES148.1153.2206.3263.3
Deferred Tax Assets, Current22.624.942.240.0
TOTAL CURRENT ASSETS206.8223.6294.9351.8
Gross Property Plant and Equipment81.7102.7133.6156.3
Accumulated Depreciation-38.1-52.3-67.9-90.0
NET PROPERTY PLANT AND EQUIPMENT43.650.465.666.4
Goodwill23.423.435.235.2
Deferred Tax Assets, Long Term1.02.32.13.4
Other Long-Term Assets1.61.82.22.5
TOTAL ASSETS283.3312.8421.5478.9
    
LIABILITIES & EQUITY    
Accrued Expenses11.816.519.615.8
Short-Term Borrowings18.6--26.133.4
Current Portion of Capital Lease Obligations3.04.05.26.1
Current Income Taxes Payable8.99.818.315.6
Other Current Liabilities, Total0.4--2.41.9
TOTAL CURRENT LIABILITIES82.572.0133.8144.6
Long-Term Debt4.64.23.73.1
Capital Leases6.49.510.712.3
Other Non-Current Liabilities----1.8--
Common Stock0.30.30.30.3
Additional Paid in Capital45.640.939.440.0
Retained Earnings143.9186.1231.9278.6
TOTAL COMMON EQUITY189.8227.2271.6318.9
TOTAL EQUITY189.8227.2271.6318.9
TOTAL LIABILITIES AND EQUITY283.3312.8421.5478.9
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BRLI:US $33.73 USD +0.3799

BRLI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Foundation Medicine Inc $46.94 USD -0.10
Genomic Health Inc $32.16 USD -0.23
Myriad Genetics Inc $37.64 USD -0.23
NeoGenomics Inc $3.95 USD +0.015
Sequenom Inc $3.60 USD -0.05
View Industry Companies
 

Industry Analysis

BRLI

Industry Average

Valuation BRLI Industry Range
Price/Earnings 19.9x
Price/Sales 1.1x
Price/Book 2.9x
Price/Cash Flow 12.9x
TEV/Sales 1.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIO-REFERENCE LABS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.